APOLLOHOSP - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 4.0

🏥 Apollo Hospitals shows strong technical momentum and institutional interest, making it a favorable candidate for intraday trading with moderate valuation caution.

📈 Positive

• 🔹 MACD at 30.1: Bullish crossover supports upward momentum.
• 🔹 RSI at 51.8: Neutral-bullish zone, offering room for upside.
• 🔹 Price Above 50 & 200 DMA: Current price (₹7,813) is above both DMAs (₹7,718 & ₹7,288), confirming trend strength.
• 🔹 FII Accumulation: Foreign institutional holdings increased by 0.71%, signaling confidence.
• 🔹 EPS of ₹94.0: Reflects strong earnings base.
• 🔹 Quarterly PAT: ₹307 Cr with 21.9% variation shows operational resilience.

⚠️ Limitation

• 🔸 High P/E Ratio: At 83.1, significantly above industry average (57.2), suggesting valuation premium.
• 🔸 PEG Ratio at 3.50: Indicates expensive growth expectations.
• 🔸 DII Outflow: Domestic institutional holdings declined by 0.22%.
• 🔸 Quarterly PAT Dip: Down from ₹333 Cr to ₹307 Cr.

🚫 Company Negative News

• 📉 Profitability Pressure: Analysts cite rising operating costs and competitive pricing in diagnostics and pharmacy segments.

✅ Company Positive News

• 🏥 Healthcare Expansion: Continued investment in digital health platforms and Tier 2 city hospital networks.
• 📈 Strong Brand Position: Apollo remains a leader in tertiary care and specialty services across India.

🏦 Industry

• 🩺 Sector: Healthcare Services — Hospitals, Diagnostics, Pharmacy Retail.
• 📊 Industry PE: 57.2, lower than APOLLOHOSP’s, indicating valuation caution.

📌 Conclusion

• 📉 Intraday Setup: Strong MACD and DMA support favor breakout trades; valuation and PAT dip warrant caution.
• 💰 Optimal Buy Price: ₹7,790–₹7,800 (near 50 DMA support).
• 📈 Profit Exit Level: ₹7,850–₹7,880 (short-term resistance zone).
• 🛑 Stop Loss: ₹7,760 (below 50 DMA).
• ⏳ If Holding: Exit if RSI dips below 50 or price fails to hold above ₹7,800 intraday.

I can also compare APOLLOHOSP’s intraday setup with other healthcare stocks showing similar MACD and RSI strength today.